Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 70069-815

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 70069-815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg-1000counts (20mg 1000counts)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg by Somerset Therapeutics LLC. The label indicates a package size of 1,000 capsules, with instructions for pharmacists to dispense the accompanying Medication Guide. It includes storage instructions, manufacturer and distributor information, barcode, and cautions.*

FDA Label Image

20mg-30counts (20mg 30counts)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, supplied by Somerset Therapeutics LLC. The label indicates the product is a prescription oral capsule in a 30-capsule package. It includes storage instructions, manufacturer details, a barcode, and a warning to keep the container tightly closed and out of reach of children.*

FDA Label Image

20mg-90counts (20mg 90counts)

Label for Esomeprazole Magnesium Delayed-Release Capsules 20 mg by Somerset Therapeutics LLC. The label shows the product name, strength, dosage form (capsules), package quantity of 90 capsules, storage instructions, and manufacturer information. A barcode and lot and expiration date areas are also visible.*

FDA Label Image

40mg-1000counts (40mg 1000counts)

Label for Esomeprazole Magnesium Delayed-Release Capsules USP 40 mg by Somerset Therapeutics LLC. The label indicates 1,000 capsules per container, with storage instructions, dosage form, and distributor information including Somerset Therapeutics, Hollywood, FL. It includes a note for pharmacists to dispense the medication guide.*

FDA Label Image

40mg-30counts (40mg 30counts)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP, 40 mg strength, in a bottle of 30 capsules. The label includes the NDC 70069-815-30 and is from Somerset Therapeutics, LLC. It contains storage instructions, a barcode, and distributor information, highlighting the capsule's delayed-release formulation and prescription-only status.*

FDA Label Image

40mg-90counts (40mg 90counts)

Label for Esomeprazole Magnesium Delayed-Release Capsules USP, 40 mg strength, oral capsules in a bottle of 90 count. The label includes manufacturer information for Somerset Therapeutics, LLC, storage instructions, safety warnings, and a note for pharmacists to dispense the medication guide. The NDC is 70069-815-90.*

FDA Label Image

Figure-2 (Figure 2)

A line graph depicting the percentage of patients maintaining a condition over six months for four groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, 10 mg, and placebo. The y-axis represents percent maintained, and the x-axis represents months, showing effectiveness trends over time for each dosage and placebo.*

FDA Label Image

Figure-3 (Figure 3)

A line graph showing percentage maintained over six months for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses, compared to placebo. The 40 mg and 20 mg doses maintain a high percentage near 100%, while the 10 mg dose and placebo show a noticeable decline over time.*

FDA Label Image

Figure-4 (Figure 4)

A line graph showing the percent of patients symptom-free over a 28-day diary period. It compares Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses with placebo. The 20 mg and 40 mg doses show a generally higher percent of symptom-free patients over time compared to placebo.*

FDA Label Image

Figure-5 (Figure 5)

A line graph showing the percent of patients symptom-free over 28 days for Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The x-axis represents diary days (0 to 28), and the y-axis shows percent symptom-free (0 to 100%). Three lines correspond to the two strengths and placebo, illustrating symptom relief trends over time.*

FDA Label Image

Ink1 (Ink1)

Esomeprazole Magnesium 40 mg delayed release capsules, oral dosage form. The label shows the product name in large font along with the strength clearly indicated. The labeler is Somerset Therapeutics, LLC. The packaging highlights that this is a prescription drug with a quantity of 30 capsules. Various regulatory and patient information symbols are visible, but specific details are not legible.*

FDA Label Image

Ink2 (Ink2)

Esomeprazole Magnesium 40 mg delayed-release capsules in a clear amber plastic bottle with a white child-resistant cap. The label includes the product name, strength, dosage form, and route of administration. The labeler is Somerset Therapeutics, LLC. The bottle contains multiple capsules visible inside.*

FDA Label Image

Ink3 (Ink3)

Esomeprazole Magnesium 40 mg delayed-release capsule blister packaging. The label shows the product name, strength (40 mg), dosage form (capsule), and labeler Somerset Therapeutics, LLC. The blister contains multiple capsules arranged in rows within a transparent plastic cover.*

FDA Label Image

Ink4 (Ink4)

Esomeprazole Magnesium 20 mg delayed-release capsules in a clear blister pack. The capsules are two-toned, with one half pink and the other half white, each imprinted with 'S 1' on the pink half. The pack is labeled with the strength, dosage form, and labeler Somerset Therapeutics, LLC.*

FDA Label Image

Structure (Structure)

Chemical structure of esomeprazole magnesium, showing the molecular arrangement including methoxy groups, sulfur, nitrogen atoms, and magnesium ion with three water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.